Compare SAH & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAH | NVAX |
|---|---|---|
| Founded | 1997 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.1B |
| IPO Year | 1997 | 1995 |
| Metric | SAH | NVAX |
|---|---|---|
| Price | $65.87 | $6.56 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 9 |
| Target Price | ★ $80.75 | $10.78 |
| AVG Volume (30 Days) | 192.4K | ★ 3.5M |
| Earning Date | 10-23-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.73 | 2.07 |
| Revenue | ★ $15,178,100,000.00 | $1,064,651,000.00 |
| Revenue This Year | $7.85 | $58.91 |
| Revenue Next Year | $3.49 | N/A |
| P/E Ratio | $17.50 | ★ $3.17 |
| Revenue Growth | 9.09 | ★ 20.27 |
| 52 Week Low | $52.00 | $5.01 |
| 52 Week High | $89.62 | $11.55 |
| Indicator | SAH | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 39.00 |
| Support Level | $64.51 | $6.43 |
| Resistance Level | $68.57 | $6.84 |
| Average True Range (ATR) | 2.14 | 0.21 |
| MACD | 0.64 | 0.04 |
| Stochastic Oscillator | 64.46 | 23.95 |
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 14 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.